Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Jyong Biotech Ltd. (MENS)

Codexis, Inc. and Jyong Biotech Ltd. are both Biotechnology companies. Codexis, Inc. and Jyong Biotech Ltd. are of similar size ($148.9M and $147.0M). Across the 5 metrics below, Jyong Biotech Ltd. leads on 3 and Codexis, Inc. on 2.

Valuation

Metric CDXS MENS Biotechnology median
P/E n/m — 8.42
P/S 1.58 — 10.01
P/B 3.73 n/m 2.21
Price to free cash flow n/m — 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.31 n/m 9.41
Earnings yield (25.19%) — (31.85%)
Free cash flow yield (9.90%) — (24.58%)

Profitability

Metric CDXS MENS Biotechnology median
Gross margin 87.02% — 65.16%
Operating margin (35.61%) — 0.00%
Net margin (39.55%) — 0.00%
Free cash flow margin (15.66%) — 0.00%
Return on equity (69.36%) — (56.36%)
Return on assets (23.79%) — (48.04%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS MENS Biotechnology median
Revenue growth (TTM) 35.89% — 6.02%
EPS growth (last fiscal year) 43.82% (42.18%) 30.26%
Revenue growth, 5-year CAGR 0.38% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CDXS MENS Biotechnology median
Debt to equity 1.03 (0.74) 0.00
Current ratio 3.06 0.45 4.72
Net debt to EBITDA 1.11 (6.89) 0.96

Dividend

Metric CDXS MENS Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CDXS MENS Biotechnology median
Market cap 148.93m 146.98m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack